PT90962A - Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal

Info

Publication number
PT90962A
PT90962A PT90962A PT9096289A PT90962A PT 90962 A PT90962 A PT 90962A PT 90962 A PT90962 A PT 90962A PT 9096289 A PT9096289 A PT 9096289A PT 90962 A PT90962 A PT 90962A
Authority
PT
Portugal
Prior art keywords
ranitidine
salt
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
PT90962A
Other languages
English (en)
Other versions
PT90962B (pt
Inventor
Alain Emile
Edouard Schaeffer
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of PT90962A publication Critical patent/PT90962A/pt
Publication of PT90962B publication Critical patent/PT90962B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT90962A 1988-06-24 1989-06-23 Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal PT90962B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (2)

Publication Number Publication Date
PT90962A true PT90962A (pt) 1989-12-29
PT90962B PT90962B (pt) 1994-12-30

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90962A PT90962B (pt) 1988-06-24 1989-06-23 Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal

Country Status (32)

Country Link
US (1) US5102665A (pt)
JP (1) JPH0786086B2 (pt)
KR (1) KR940002662B1 (pt)
AT (1) AT396426B (pt)
AU (1) AU627194B2 (pt)
BE (1) BE1005691A4 (pt)
CA (1) CA1329130C (pt)
CH (1) CH679276A5 (pt)
CY (1) CY1637A (pt)
CZ (1) CZ280886B6 (pt)
DE (1) DE3920626C2 (pt)
DK (1) DK170223B1 (pt)
ES (1) ES2015717A6 (pt)
FR (1) FR2633181B1 (pt)
GB (1) GB2219940B (pt)
HK (1) HK33192A (pt)
HU (1) HU210067A9 (pt)
IE (1) IE60725B1 (pt)
IL (1) IL90731A (pt)
IT (1) IT1232149B (pt)
LU (1) LU87541A1 (pt)
MY (1) MY106412A (pt)
NL (1) NL8901596A (pt)
NZ (1) NZ229698A (pt)
PH (1) PH26018A (pt)
PT (1) PT90962B (pt)
SA (1) SA90100095B1 (pt)
SE (1) SE502285C2 (pt)
SG (1) SG21892G (pt)
SK (1) SK403891A3 (pt)
ZA (1) ZA894787B (pt)
ZW (1) ZW7889A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP2000511178A (ja) * 1996-05-17 2000-08-29 メルク エンド カンパニー インコーポレーテッド 発泡性ビスホスホネート製剤
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
WO2002089823A1 (fr) * 2001-04-27 2002-11-14 Kyoto Pharmaceutical Industries, Ltd. Methode de conservation pour un suppositoire
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US20050142197A1 (en) * 2003-12-31 2005-06-30 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
CN101484132A (zh) * 2007-07-09 2009-07-15 柏树制药公司 具有合意口味的雷尼替丁制剂
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
IE60725B1 (en) 1994-08-10
ES2015717A6 (es) 1990-09-01
PH26018A (en) 1992-01-29
DK170223B1 (da) 1995-07-03
NL8901596A (nl) 1990-01-16
SE8902288L (sv) 1989-12-25
NZ229698A (en) 1991-05-28
IT1232149B (it) 1992-01-25
ZA894787B (en) 1990-03-28
MY106412A (en) 1995-05-30
SK278823B6 (sk) 1998-03-04
GB2219940B (en) 1992-01-02
HK33192A (en) 1992-05-15
BE1005691A4 (fr) 1993-12-21
JPH0245421A (ja) 1990-02-15
US5102665A (en) 1992-04-07
DE3920626C2 (de) 1994-12-22
LU87541A1 (fr) 1990-02-28
CZ280886B6 (cs) 1996-04-17
IL90731A0 (en) 1990-01-18
FR2633181B1 (fr) 1992-01-10
SA90100095B1 (ar) 1999-06-30
FR2633181A1 (fr) 1989-12-29
AU3674489A (en) 1990-01-04
CA1329130C (en) 1994-05-03
IE892047L (en) 1989-12-24
HU210067A9 (en) 1995-02-28
CY1637A (en) 1992-11-06
SG21892G (en) 1992-04-16
ATA154489A (de) 1993-01-15
AU627194B2 (en) 1992-08-20
DK314089D0 (da) 1989-06-23
IT8948116A0 (it) 1989-06-22
KR910000100A (ko) 1991-01-29
ZW7889A1 (en) 1990-02-21
DE3920626A1 (de) 1989-12-28
GB8914428D0 (en) 1989-08-09
SE502285C2 (sv) 1995-09-25
SE8902288D0 (sv) 1989-06-22
PT90962B (pt) 1994-12-30
JPH0786086B2 (ja) 1995-09-20
AT396426B (de) 1993-09-27
GB2219940A (en) 1989-12-28
IL90731A (en) 1994-04-12
CZ403891A3 (en) 1993-08-11
DK314089A (da) 1989-12-25
KR940002662B1 (ko) 1994-03-28
SK403891A3 (en) 1998-03-04
CH679276A5 (pt) 1992-01-31

Similar Documents

Publication Publication Date Title
PT90962A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
PT87958A (pt) Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3
PT90523A (pt) Processo para a preparacao de adsorvatos de ranitidina
PT87259A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 17-cetoesteroides apropriadas para o tratamento e a profilaxia de infeccoes retrovirais
ES2011210A4 (es) Derivados de gem-difosfonato subtituido por fenol, proceso para su preparacion y composiciones farmaceuticas conteniendolos
PT93633A (pt) Processo para a preparacao de composicoes biocidas contendo pelo menos um derivado de isotiazolinona ou de isotiazolotiona
PT90295A (pt) Processo para a preparacao de biciclodionas substituidas por arilo ou heteroarilo
PT89661A (pt) Processo para a preparacao de compostos pirrolicos substituidos e de composicoes farmaceuticas que os contem
PT87190A (pt) Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
PT92120A (pt) Processo para a preparacao de composicoes oftalmologicas contendo ciclosporina
PT90708A (pt) Processo para a preparacao de derivados de benzopirano
PT84530B (pt) Processo para a preparacao de 2-azolilmetil-2-aril-1,3-dioxolanos, dos seus sais e de composicoes farmaceuticas que os contem
MX164971B (es) Procedimiento para la preparacion de conjugados de medicamentos citoxicos
PT80708B (pt) Processo aperfeicoado para a preparacao de derivados de benzenossulfonamida
PT89497A (pt) Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem
PT90474A (pt) Processo para a preparacao de composicoes preservativas contendo misturas de biocidas de isotiazolonas
PT90888A (pt) Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
PT90224A (pt) Processo para a preparacao de composicoes sinergicas contendo imazalilo
BR8902915A (pt) Composicao microbicida e processo para a preparacao de compostos
PT81714B (pt) Processo para a preparacao de composicoes farmaceuticas de teofilina com efeito retardado
PT88260A (pt) Processo para a preparacao de derivados de imidazopiridazina com actividade citotoxica
PT90753A (pt) Processo processo para a preparacao de composicoes farmaceuticas para o tratamento da artrite, contendo pelo menos um analogo da somatostativa ou um seu derivado
PT81605B (pt) Processo para a preparacao de derivados de imidazolilalquil-guanidina e de composicoes farmaceuticas contendo estes compostos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940620

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090623